 |
|
|
|
 |
|
|
| Article 1 to 10 out of 15 concerning Invitrogen Corporation
|
-
Invitrogen, Agilent Technologies Settle Multiple Patent Litigations
(08 Feb 2008)
Settlement resolves all pending patent litigations between two companies
Invitrogen Corporation (IVGN) and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. The settlement resolves three patent infringement lawsuits between Invitrogen ...
-
Gendux Announces Acceptance of its ADVEXIN Marketing Authorization Application for Review by the EMEA
(29 Nov 2007)
Gene therapy targeting inherited cancer is world's first
Gendux Molecular Limited announced that its Marketing Authorization Application (MAA) for ADVEXIN® ("contusugene ladenovec" ) has been accepted for technical review by the European medicines regulatory authority (the "EMEA") for the treatment of an ...
-
Invitrogen Partners with Cytori to Offer Adipose Stem Cell Research Products
(10 May 2007)
Invitrogen Corporation and Cytori Therapeutics entered into a global strategic supply and commercialization agreement to offer adipose-derived stem cell-based research products to life science researchers. Invitrogen will offer Cytori's stem cell ...
-
Ryogen Licenses Human Aminopeptidase P Gene Patent to Invitrogen
(15 Jan 2007)
Ryogen LLC announced that the company have entered into a nonexclusive license agreement with Invitrogen Corporation, whereby Invitrogen has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene.The US Patent ...
-
Invitrogen Licenses Geron Intellectual Property for Development of Research Tools
(04 Jul 2006)
Invitrogen Corporation and Geron Corporation announced that Invitrogen has licensed Geron intellectual property related to the growth of human embryonic stem cells (hESCs). The agreement provides Invitrogen with a non-exclusive license under Geron's ...
-
Invitrogen to Hold Annual Global Volunteer Day; More Than 1,000 Employees Worldwide Giving Back to Their Communities
(26 Jul 2005)
Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company, will hold its second annual global volunteer day on Thursday, July 28 with 19 locations participating around the world. Approximately 1,300 employees worldwide will take part in ...
-
Acambis expands manufacturing capability with acquisition of US-based fill/finish facility
(06 Jul 2005)
Acambis plc announced that it has acquired a US-based fill/finish facility from BioReliance Corporation ("BioReliance"), a wholly owned subsidiary of Invitrogen Corporation.With the acquisition, Acambis intends to develop a commercial-scale ...
-
Qiagen and Invitrogen Revealed as Top Suppliers in the RNA Purification Market
(30 Jun 2005)
A recent survey reveals that more than 60% of scientists cited Qiagen as their primary supplier of RNA purification kits and more than 45% identified Invitrogen as their primary supplier of commercial reagents. With almost one-third of scientists ...
-
Dynal Biotech: Magnetic Bead Chromatography: No Columns Required
(07 Jun 2005)
Dynal Biotech, a subsidiary of Invitrogen Corporation announced the release of the first two products in its new proteomic preparation range - weak cation exchange (WCX) Dynabeads(r) and reversed phase chromatography (RPC) Dynabeads(r). These novel ...
-
Acambis expands manufacturing capability with acquisition of US-based fill/finish facility
(17 May 2005)
Acambis plc announced that it has acquired a US-based fill/finish facility from BioReliance Corporation, a wholly owned subsidiary of Invitrogen Corporation. With the acquisition, Acambis intends to develop a commercial-scale fill/finish capability ...
Additional information
Invitrogen Corporation
Carlsbad, CA, United States of America
Company
|
|
|
|
|
|
Top
